Presumptive fatality due to pyrimethamine-sulfadoxine.
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced*; D006801:Humans; D008288:Malaria / Q000517:prevention & control*; D008297:Male; D011739:Pyrimethamine / Q000009:adverse effects*; D013413:Sulfadoxine / Q000009:adverse effects*; D013424:Sulfanilamides / Q000009:adverse effects*
D013424:Sulfanilamides; D013413:Sulfadoxine; D011739:Pyrimethamine